3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Conditions
Motor Activity
55
Breast Neoplasms
29
Neoplasms
25
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Colorectal Neoplasms
6
Colonic Neoplasms
6
Polycystic Ovary Syndrome
5
Pancreatic Neoplasms
5
Obesity
5
Lymphoma
5
Fatigue
5
Multiple Myeloma
4
Lymphoma, Follicular
4
Lymphedema
4
Esophageal Neoplasms
4
Brain Neoplasms
4
Stomach Neoplasms
3
Prostatic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Leukemia
3
Hematologic Neoplasms
3
Skin Neoplasms
2
Sarcopenia
2
Recurrence
2
Rectal Neoplasms
2
Peripheral Nervous System Diseases
2
Neoplasm Metastasis
2
Melanoma
2
Interventions
pembrolizumab
2
enfortumab vedotin
2
Tablets
2
Exercise
2
Acupuncture Therapy
2
nicotinamide-beta-riboside
1
Vitamin B Complex
1
Thioctic Acid
1
Tadalafil
1
Single Person
1
Rosuvastatin Calcium
1
Omeprazole
1
Memantine
1
Massage
1
Lenalidomide
1
Gloves, Surgical
1
Fish Oils
1
Fenofibrate
1
Exercise Therapy
1
Dexamethasone
1
Cryotherapy
1
Corn Oil
1
Control Groups
1
Bortezomib
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Peripheral Nervous System Diseases
×
Exercise
×
1 year
×
Clear all
NCT07548476
2026-05-04
ACE
Dana-Farber Cancer Institute
Phase NA
Not yet recruiting
50 enrolled
NCT07150117
2026-03-12
CYCLE-CIPN
University of Alberta
Phase NA
Recruiting
30 enrolled